Francesco Ciompi

Radboud University Medical Center in Nijmegen, The Netherlands is advertising a Postdoctoral Researcher in Precision Immuno-Oncology and Biomarker Development . The project is embedded in the Department of Pulmonary Diseases , in close collaboration with the Department of Pharmacy, Pharmacology & Toxicology . The research uses the unique multimodal dataset generated by the DEDICATION-1 trial , including multi-omics , digital pathology (H&E and PD-L1 slides), immunological data, and clinical data from patients with advanced-stage non-small cell lung cancer . The aim is to develop data-driven decision support tools for precision immuno-oncology , with a focus on predicting response to immunotherapy and tailoring treatment to individual patients with thoracic malignancies based on tumour and patient characteristics. The post also highlights computational biomarker development, including digital pathology and AI-oriented analysis. This is a postdoctoral opening , not a scholarship or studentship. No stipend, tuition, or fee waiver is mentioned in the post. The vacancy is based at the Radboud University Medical Center campus in Nijmegen. Applicants should be prepared to work with complex clinical and biomedical datasets and contribute to translational cancer research. The post does not list detailed eligibility criteria in the provided text, so interested candidates should consult the full vacancy page for formal requirements and application instructions. Application is via the vacancy link shared in the post.